RC-3095, a selective GRPR antagonist, has been shown to have anti-inflammatory properties in different models of inflammation.

138147-78-1

C56H79N15O9

1106.32

RC-3095

H2O:Soluble
Powder: -20°C for 3 years
In solvent: -80°C for 2 years